Compounds > linsidomine
Page last updated: 2024-08-16

linsidomine and alpha-synuclein

linsidomine has been researched along with alpha-synuclein in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ebadi, M; Sharma, SK1
Andreatta, C; Hanson, AJ; Kumar, B; Nahreini, P; Prasad, JE; Prasad, KN; Yan, XD1
Lev, N; Melamed, E; Offen, D1
Dawson, TM; Dawson, VL; Holmes, S; Jiang, H; Liang, Y; Nakamura, M; Ross, CA; Smith, WW; Tanaka, Y; Wu, YC1
Ayton, S; Barnham, KJ; Bush, AI; Cappai, R; Cheng, L; Cherny, RA; Chiu, FC; Crouch, PJ; Culvenor, JG; Donnelly, PS; Finkelstein, DI; George, J; Hill, AF; Hung, LW; Leong, SL; Lim, S; Liu, X; Masters, CL; O'Keefe, G; Pham, CL; Powell, AK; Roberts, BR; Shackleford, DM; Sherratt, NA; Villemagne, VL; White, AR; Wilkins, S1

Other Studies

5 other study(ies) available for linsidomine and alpha-synuclein

ArticleYear
Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.
    Antioxidants & redox signaling, 2003, Volume: 5, Issue:3

    Topics: alpha-Synuclein; Animals; Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; Corpus Striatum; Deoxyadenosines; Dopamine; Gene Expression Regulation; Humans; Lipid Peroxidation; Metallothionein; Metals; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Molsidomine; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Oxidative Stress; Selegiline; Stem Cells; Synucleins; Transcriptional Activation

2003
Overexpression of alpha-synuclein decreased viability and enhanced sensitivity to prostaglandin E(2), hydrogen peroxide, and a nitric oxide donor in differentiated neuroblastoma cells.
    Journal of neuroscience research, 2004, May-01, Volume: 76, Issue:3

    Topics: alpha-Synuclein; Animals; Cell Differentiation; Cell Survival; Dinoprostone; Dose-Response Relationship, Drug; Humans; Hydrogen Peroxide; Mice; Molsidomine; Nerve Tissue Proteins; Neuroblastoma; Nitric Oxide Donors; Synucleins; Transfection; Tumor Cells, Cultured

2004
Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage.
    Neuroscience letters, 2006, May-15, Volume: 399, Issue:1-2

    Topics: alpha-Synuclein; Benzothiazoles; Cell Differentiation; Cell Line, Tumor; Cytoplasm; Ferrous Compounds; Humans; Immunohistochemistry; Molsidomine; Mutation; Neuroblastoma; Oxidative Stress; Parkinson Disease; Proteasome Inhibitors; Reactive Oxygen Species; Rotenone; Thiazoles; Ubiquitin

2006
Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
    Neurobiology of aging, 2007, Volume: 28, Issue:11

    Topics: alpha-Synuclein; Animals; Cell Death; Dose-Response Relationship, Drug; Genetic Predisposition to Disease; Hydrogen Peroxide; Molsidomine; Mutation; Parkinson Disease; PC12 Cells; Rats; Reactive Oxygen Species

2007
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease.
    The Journal of experimental medicine, 2012, Apr-09, Volume: 209, Issue:4

    Topics: alpha-Synuclein; Animals; Cell Line, Tumor; Cognition; Coordination Complexes; Disease Models, Animal; Humans; Male; Mice; Mice, Inbred C57BL; Molsidomine; Motor Activity; Neuroprotective Agents; Organometallic Compounds; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Thiosemicarbazones

2012